mitochondria

Recent advancements in mitochondrial genome editing technologies take scientists one step closer to developing viable treatments for mitochondrial diseases, which affect 1 in 4300 adults.

Philip Yeske was an organic chemist for more than 20 years, but when his daughter died from the rare mitochondrial disorder Leigh Syndrome, he turned to connecting researchers, patients, and law makers to speed the discovery of treatments.

USC’s ‘exercise protein’ doubles running capacity and extends healthy lifespans in older mice

Early research shows how mild defects in mitochondria can lead to behaviors similar to those seen in autism